Disproportional response: a small company's current business is visibly outgrowing its own size
The model's full reasoning — Q1 2022 call → NOWe need to determine if management conveys that the company is small and that current activity/demand/commitments are disproportionately large relative to that smallness. The transcript includes discussion of ModeX acquisition, BioReference, COVID testing, etc. Management describes growth in certain segments, but does it convey a sense of smallness with disproportionately large current business? For example, they mention that noninvasive prenatal testing grew 219% year-over-year, but that's a growth rate, not necessarily a disproportion relative to company size. They also mention that they are adding hospitals, schools, ships, etc. But the overall company revenue is $1.1-1.2 billion, so it's not tiny. The ModeX acquisition is a new venture, but that's a strategic move, not necessarily current business arriving at scale. The question asks: does management describe current activity, demand, or commitments arriving at a scale that is large relative to how small the company still is? The company is not small; it's a mid-cap with significant revenue. Management does not explicitly say "we are small and this is huge relative to us." They talk about growth and opportunities, but not in a way that conveys disproportion. They mention that COVID testing is declining, but they have a steady flow. They also mention that they are investing in commercial organization. There is no statement like "this single contract could double our revenue" or "we are a small company and this is massive." So answer NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| TMCI | Treace Medical Concepts, Inc. | Q2 2022 | 2022-08-13 | B+ |
| VNRX | VolitionRx Limited | Q1 2022 | 2022-05-12 | F |
| FLUX | Flux Power Holdings, Inc. | Q2 2022 | 2022-02-10 | D |
VNRX · Q1 2022 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES The transcript shows management explicitly describing the Heska deal (already signed and with $10M upfront received) as a long-term, multi-year commitment that will generate ongoing kit/component revenue "significantly greater" than the $28M milestones, with "millions of tests" expected each year — all while repeatedly noting the company is "not a big company" and that this is "the beginning of our commercial journey" after 12 years of R&D. They contrast this with their tiny current revenue ($114k) and cash position, framing the new activity as disproportionately large relative to their size.
TMCI · Q2 2022 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES Management explicitly describes the business as outgrowing its current setup in present-tense terms: they are “once again in the process of relocating to a larger headquarters facility” to meet “increased requirements” for training, R&D, warehousing, and infrastructure; the direct sales force has grown 52% to 123 quota-carrying reps and is already trending above the year-end 70% direct mix goal; surgeon penetration has reached 20% of the estimated 10,000 U.S. foot-and-ankle surgeons while procedure penetration is 4.6% of the 450,000 annual U.S.
KOPN · Q4 2023 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES The transcript shows management describing current activity (a $55 million backlog, a $20.5 million new order, follow-on orders, and tripled weapon-site volume expected in 2024) as large relative to the company’s still-small size and setup. They explicitly note the backlog is a “record level 10 years,” that they had to extend the holiday shutdown and retool the plant for a “significant increase in production,” and that they are “buying to that level of volume today” while remaining conservative on guidance.